LOAR MATTHEW M
Insider CIK 1236260 · TSPT Director · OXGN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MATN MATEON THERAPEUTICS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 500,000 | — | $0 | 500,000 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 250,000 | — | $0 | 250,000 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | P Buy deriv | 2018-04-12 | 2018-04-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | P Buy deriv | 2018-04-12 | 2018-04-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | P Buy | 2018-04-12 | 2018-04-16 | 250,000 | — | $0 | 300,000 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | A Award deriv | 2017-01-12 | 2017-01-13 | 350,000 | $0.38 | $133.0K | 350,000 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2016-03-21 | 2016-03-23 | 262,500 | — | $0 | 262,500 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2015-07-20 | 2015-07-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 2,083 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-12-16 | 2013-12-17 | 25,000 | — | $0 | 25,000 | SEC↗ |